Beam Therapeutics’ first clinical data in the rare disease alpha-1 antitrypsin deficiency “set a bar for efficacy in the space,” according to one analyst. But the ongoing market slide poses challenges for biotech companies aiming to raise money by selling stock. The post Beam Base Editor’s Early Data in Rare Liver Disease Tee Up $500M…
Usage Guidelines KFF encourages other organizations to embed the Health Insurance Marketplace Calculator on their websites. To do so, follow the instructions below. Please do not alter the embed code in any way without advanced permission.The calculator widget is intended to be embedded in areas between 300 px and 800 px wide and will expand to…More
By KIM BELLARD I feel like I’ve been writing a lot about futures I was pretty worried about, so I’m pleased to have a couple developments to talk about that help remind me that technology is cool and that healthcare can surely use more of it. First up is a new AI algorithm called FaceAge,…
Roche’s Tecentriq Hybreza is a subcutaneously injectable formulation of the cancer drug Tecentriq while Ocrevus Zunovo is an injectable version of multiple sclerosis drug Ocrevus. Each is administered in minutes compared to an hour or more for infused therapies. The post Roche Welcomes FDA Approvals for Injectable Versions of MS and Cancer Drugs appeared first…
Across the U.S., nearly 700 rural hospitals are at risk of closure. When they shut down, the impacts cascade: broken continuity, delayed care, and increased cyber risk in every new system a patient must navigate. The post The Hidden Fallout of Rural Hospital Closures: Patient Care Suffers – and So Does Data Security appeared first…
DENVER — Seven years ago, Erica Green learned through a Facebook post that her brother had been shot. She rushed to check on him at a hospital run by Denver Health, the city’s safety-net system, but she was unable to get information from emergency room workers, who complained that she was creating a disturbance. “I…
[Sponsored] For many people, migraines interfere with daily life, work and relationships. Understanding what’s behind them — and how to manage them naturally — can be a powerful step toward lasting relief. The post The Best Way to Manage Migraines Without Medication appeared first on MedCity News.
To be clear, this doesn’t mean healthcare organizations should adopt LLMs tomorrow. But what’s changed is that the primary obstacle – cost at scale – is no longer the immovable obstacle it once was. For healthcare leaders who have been watching the AI wave from the sidelines, this is the moment to move from curiosity…
The Host Julie Rovner KFF Health News @jrovner Read Julie’s stories. Julie Rovner is chief Washington correspondent and host of KFF Health News’ weekly health policy news podcast, “What the Health?” A noted expert on health policy issues, Julie is the author of the critically praised reference book “Health Care Politics and Policy A to…
MedCity INVEST Digital Health on September 18 at Pegasus Park in Dallas will explore AI through a series of discussions leading up to our annual Pitch Perfect contest, where healthcare startups pitch their companies to a team of investor judges. Register today! The post Navigating the AI in Healthcare Landscape and Its Future: A Preview…